Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Long-Term Investments (2021 - 2025)

Historic Long-Term Investments for Precision Biosciences (DTIL) over the last 5 years, with Q3 2025 value amounting to $744000.0.

  • Precision Biosciences' Long-Term Investments fell 7679.35% to $744000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $744000.0, marking a year-over-year decrease of 7679.35%. This contributed to the annual value of $3.2 million for FY2024, which is 0.0% changed from last year.
  • Per Precision Biosciences' latest filing, its Long-Term Investments stood at $744000.0 for Q3 2025, which was down 7679.35% from $744000.0 recorded in Q2 2025.
  • Over the past 5 years, Precision Biosciences' Long-Term Investments peaked at $3.8 million during Q4 2021, and registered a low of $744000.0 during Q2 2025.
  • Over the past 5 years, Precision Biosciences' median Long-Term Investments value was $3.1 million (recorded in 2022), while the average stood at $2.5 million.
  • Per our database at Business Quant, Precision Biosciences' Long-Term Investments skyrocketed by 28066.5% in 2022 and then crashed by 7679.35% in 2025.
  • Precision Biosciences' Long-Term Investments (Quarter) stood at $3.8 million in 2021, then tumbled by 31.32% to $2.6 million in 2022, then increased by 24.46% to $3.2 million in 2023, then changed by 0.0% to $3.2 million in 2024, then plummeted by 76.79% to $744000.0 in 2025.
  • Its Long-Term Investments stands at $744000.0 for Q3 2025, versus $744000.0 for Q2 2025 and $3.2 million for Q1 2025.